Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2001 Jan;54(1):20–24. doi: 10.1136/jcp.54.1.20

Preoperative assessment of prognostic factors in breast cancer

H Denley 1, S Pinder 1, C Elston 1, A Lee 1, I Ellis 1
PMCID: PMC1731277  PMID: 11271783

Abstract

The adoption of preoperative diagnostic strategies involving fine needle aspiration cytology (FNAC) or core biopsy is well established, allowing the planning of operating lists and bed occupancy and patient involvement in therapeutic management. In addition to diagnosis, however, pathologists are increasingly being asked to provide pathological prognostic information from preoperative samples. This leader describes techniques for predicting prognosis and response to treatment on these specimens and some of the problems inherent in the determination of prognosis on small samples. For example, although histological grade can be assessed relatively reliably on either core or FNAC samples, the evaluation of tumour type (which includes an overall assessment of the architecture of a given tumour) may be less reliable on small preoperative samples. Other well recognised histological prognostic factors, such as vascular channel invasion or tumour size, cannot be determined accurately on small preoperative samples. For those patients who might benefit from neoadjuvant treatment, predicting the response to such treatments—for example, by the assessment of oestrogen receptor status—can readily be performed on either core biopsy or FNAC. In the future, other molecular markers such as C-erbB-2 might also prove beneficial in predicting response to newly developed treatments.

Key Words: breast cancer • fine needle aspiration cytology • needle core biopsy • tumour grade

Full Text

The Full Text of this article is available as a PDF (109.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Dublin E. A., Fisher C. J., Levison D. A., Millis R. R. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum Pathol. 1993 May;24(5):469–476. doi: 10.1016/0046-8177(93)90158-d. [DOI] [PubMed] [Google Scholar]
  2. Carter C. L., Allen C., Henson D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989 Jan 1;63(1):181–187. doi: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  3. Cheung P. S., Yan K. W., Alagaratnam T. T. The complementary role of fine needle aspiration cytology and Tru-cut needle biopsy in the management of breast masses. Aust N Z J Surg. 1987 Sep;57(9):615–620. doi: 10.1111/j.1445-2197.1987.tb01436.x. [DOI] [PubMed] [Google Scholar]
  4. Ciatto S., Bonardi R., Herd-Smith A., Cariaggi P., Confortini M., Bulgaresi P. Prognostic value of breast cancer cytologic grading: a retrospective study of 213 cases. Diagn Cytopathol. 1993;9(2):160–163. doi: 10.1002/dc.2840090210. [DOI] [PubMed] [Google Scholar]
  5. Clark G. M. Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat. 1994;30(2):117–126. doi: 10.1007/BF00666054. [DOI] [PubMed] [Google Scholar]
  6. Dabbs D. J. Role of nuclear grading of breast carcinomas in fine needle aspiration specimens. Acta Cytol. 1993 May-Jun;37(3):361–366. [PubMed] [Google Scholar]
  7. Dabbs D. J., Silverman J. F. Prognostic factors from the fine-needle aspirate: breast carcinoma nuclear grade. Diagn Cytopathol. 1994;10(3):203–208. doi: 10.1002/dc.2840100302. [DOI] [PubMed] [Google Scholar]
  8. Dahlstrom J. E., Jain S., Sutton T., Sutton S. Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme. Histopathology. 1996 May;28(5):421–427. doi: 10.1046/j.1365-2559.1996.332376.x. [DOI] [PubMed] [Google Scholar]
  9. Dahlstrom J. E., Sutton S., Jain S. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Histopathology. 1996 Jun;28(6):537–541. doi: 10.1046/j.1365-2559.1996.d01-463.x. [DOI] [PubMed] [Google Scholar]
  10. Dalton L. W., Page D. L., Dupont W. D. Histologic grading of breast carcinoma. A reproducibility study. Cancer. 1994 Jun 1;73(11):2765–2770. doi: 10.1002/1097-0142(19940601)73:11<2765::aid-cncr2820731119>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  11. Dawson P. J., Ferguson D. J., Karrison T. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer. 1982 Nov 15;50(10):2131–2138. doi: 10.1002/1097-0142(19821115)50:10<2131::aid-cncr2820501027>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  12. Devine P. L., McKenzie I. F. Mucins: structure, function, and associations with malignancy. Bioessays. 1992 Sep;14(9):619–625. doi: 10.1002/bies.950140909. [DOI] [PubMed] [Google Scholar]
  13. Dixon J. M., Page D. L., Anderson T. J., Lee D., Elton R. A., Stewart H. J., Forrest A. P. Long-term survivors after breast cancer. Br J Surg. 1985 Jun;72(6):445–448. doi: 10.1002/bjs.1800720614. [DOI] [PubMed] [Google Scholar]
  14. Djavan B., Kadesky K., Klopukh B., Marberger M., Roehrborn C. G. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol. 1998;33(3):261–270. doi: 10.1159/000019578. [DOI] [PubMed] [Google Scholar]
  15. Dowle C. S., Owainati A., Robins A., Burns K., Ellis I. O., Elston C. W., Blamey R. W. Prognostic significance of the DNA content of human breast cancer. Br J Surg. 1987 Feb;74(2):133–136. doi: 10.1002/bjs.1800740221. [DOI] [PubMed] [Google Scholar]
  16. Ellis I. O., Bell J., Todd J. M., Williams M., Dowle C., Robins A. R., Elston C. W., Blamey R. W., Baldwin R. W. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. Br J Cancer. 1987 Sep;56(3):295–299. doi: 10.1038/bjc.1987.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ellis I. O., Galea M., Broughton N., Locker A., Blamey R. W., Elston C. W. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology. 1992 Jun;20(6):479–489. doi: 10.1111/j.1365-2559.1992.tb01032.x. [DOI] [PubMed] [Google Scholar]
  18. Elston C. W., Ellis I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403–410. doi: 10.1111/j.1365-2559.1991.tb00229.x. [DOI] [PubMed] [Google Scholar]
  19. Elston C. W., Ellis I. O., Pinder S. E. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol. 1999 Aug;31(3):209–223. doi: 10.1016/s1040-8428(99)00034-7. [DOI] [PubMed] [Google Scholar]
  20. Elston C. W., Gresham G. A., Rao G. S., Zebro T., Haybittle J. L., Houghton J., Kearney G. The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. Br J Cancer. 1982 May;45(5):655–669. doi: 10.1038/bjc.1982.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fisher E. R., Sass R., Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer. 1984 Feb 1;53(3 Suppl):712–723. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  22. Frable W. J. Needle aspiration biopsy: past, present, and future. Hum Pathol. 1989 Jun;20(6):504–517. doi: 10.1016/0046-8177(89)90242-6. [DOI] [PubMed] [Google Scholar]
  23. Frierson H. F., Jr, Wolber R. A., Berean K. W., Franquemont D. W., Gaffey M. J., Boyd J. C., Wilbur D. C. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol. 1995 Feb;103(2):195–198. doi: 10.1093/ajcp/103.2.195. [DOI] [PubMed] [Google Scholar]
  24. Galea M. H., Blamey R. W., Elston C. E., Ellis I. O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22(3):207–219. doi: 10.1007/BF01840834. [DOI] [PubMed] [Google Scholar]
  25. Gonzalez M. A., Pinder S. E., Wencyk P. M., Bell J. A., Elston C. W., Nicholson R. I., Robertson J. F., Blamey R. W., Ellis I. O. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol. 1999 Apr;187(5):523–529. doi: 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  26. Harris A. L. What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer? Breast Cancer Res Treat. 1994 Jan;29(1):1–2. doi: 10.1007/BF00666176. [DOI] [PubMed] [Google Scholar]
  27. Haybittle J. L., Blamey R. W., Elston C. W., Johnson J., Doyle P. J., Campbell F. C., Nicholson R. I., Griffiths K. A prognostic index in primary breast cancer. Br J Cancer. 1982 Mar;45(3):361–366. doi: 10.1038/bjc.1982.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hunt C. M., Ellis I. O., Elston C. W., Locker A., Pearson D., Blamey R. W. Cytological grading of breast carcinoma--a feasible proposition? Cytopathology. 1990;1(5):287–295. doi: 10.1111/j.1365-2303.1990.tb00362.x. [DOI] [PubMed] [Google Scholar]
  29. Iczkowski K. A., Bostwick D. G. The pathologist as optimist: cancer grade deflation in prostatic needle biopsies. Am J Surg Pathol. 1998 Oct;22(10):1169–1170. doi: 10.1097/00000478-199810000-00001. [DOI] [PubMed] [Google Scholar]
  30. Joensuu H., Toikkanen S., Isola J. Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer. 1995 Jan;71(1):155–159. doi: 10.1038/bjc.1995.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lamb J., Anderson T. J., Dixon M. J., Levack P. A. Role of fine needle aspiration cytology in breast cancer screening. J Clin Pathol. 1987 Jul;40(7):705–709. doi: 10.1136/jcp.40.7.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Langmuir V. K., Cramer S. F., Hood M. E. Fine needle aspiration cytology in the management of palpable benign and malignant breast disease. Correlation with clinical and mammographic findings. Acta Cytol. 1989 Jan-Feb;33(1):93–98. [PubMed] [Google Scholar]
  33. Lee K. R., Foster R. S., Papillo J. L. Fine needle aspiration of the breast. Importance of the aspirator. Acta Cytol. 1987 May-Jun;31(3):281–284. [PubMed] [Google Scholar]
  34. Liberman L., Dershaw D. D., Rosen P. P., Abramson A. F., Deutch B. M., Hann L. E. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology. 1994 Sep;192(3):793–795. doi: 10.1148/radiology.192.3.8058949. [DOI] [PubMed] [Google Scholar]
  35. Litherland J. C., Evans A. J., Wilson A. R., Kollias J., Pinder S. E., Elston C. W., Ellis I. O., Yeoman L. J. The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. Clin Radiol. 1996 Aug;51(8):562–565. doi: 10.1016/s0009-9260(96)80136-x. [DOI] [PubMed] [Google Scholar]
  36. Locker A. P., Dowle C. S., Ellis I. O., Elston C. W., Blamey R. W., Sikora K., Evan G., Robins R. A. c-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer. 1989 Nov;60(5):669–672. doi: 10.1038/bjc.1989.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Lovekin C., Ellis I. O., Locker A., Robertson J. F., Bell J., Nicholson R., Gullick W. J., Elston C. W., Blamey R. W. c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer. 1991 Mar;63(3):439–443. doi: 10.1038/bjc.1991.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. McCarty K. S., Jr, Miller L. S., Cox E. B., Konrath J., McCarty K. S., Sr Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985 Aug;109(8):716–721. [PubMed] [Google Scholar]
  39. Miller W. R., Ellis I. O., Sainsbury J. R., Dixon J. M. ABC of breast diseases. Prognostic factors. BMJ. 1994 Dec 10;309(6968):1573–1576. doi: 10.1136/bmj.309.6968.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mouriquand J., Gozlan-Fior M., Villemain D., Bouchet Y., Sage J. C., Mermet M. A., Bolla M. Value of cytoprognostic classification in breast carcinomas. J Clin Pathol. 1986 May;39(5):489–496. doi: 10.1136/jcp.39.5.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Negri S., Bonetti F., Capitanio A., Bonzanini M. Preoperative diagnostic accuracy of fine-needle aspiration in the management of breast lesions: comparison of specificity and sensitivity with clinical examination, mammography, echography, and thermography in 249 patients. Diagn Cytopathol. 1994;11(1):4–8. doi: 10.1002/dc.2840110103. [DOI] [PubMed] [Google Scholar]
  42. Neville A. M., Bettelheim R., Gelber R. D., Säve-Söderbergh J., Davis B. W., Reed R., Torhorst J., Golouh R., Peterson H. F., Price K. N. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol. 1992 May;10(5):696–705. doi: 10.1200/JCO.1992.10.5.696. [DOI] [PubMed] [Google Scholar]
  43. O'Donoghue A. E., Poller D. N., Bell J. A., Galea M. H., Elston C. W., Blamey R. W., Ellis I. O. Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat. 1995;33(2):137–145. doi: 10.1007/BF00682721. [DOI] [PubMed] [Google Scholar]
  44. Pain J. A., Ebbs S. R., Hern R. P., Lowe S., Bradbeer J. W. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol. 1992 Feb;18(1):44–48. [PubMed] [Google Scholar]
  45. Parker S. H., Burbank F., Jackman R. J., Aucreman C. J., Cardenosa G., Cink T. M., Coscia J. L., Jr, Eklund G. W., Evans W. P., 3rd, Garver P. R. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology. 1994 Nov;193(2):359–364. doi: 10.1148/radiology.193.2.7972743. [DOI] [PubMed] [Google Scholar]
  46. Pereira H., Pinder S. E., Sibbering D. M., Galea M. H., Elston C. W., Blamey R. W., Robertson J. F., Ellis I. O. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 1995 Sep;27(3):219–226. doi: 10.1111/j.1365-2559.1995.tb00213.x. [DOI] [PubMed] [Google Scholar]
  47. Pinder S. E., Ellis I. O., Galea M., O'Rouke S., Blamey R. W., Elston C. W. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994 Jan;24(1):41–47. doi: 10.1111/j.1365-2559.1994.tb01269.x. [DOI] [PubMed] [Google Scholar]
  48. Pinder S. E., Elston C. W., Ellis I. O. The role of pre-operative diagnosis in breast cancer. Histopathology. 1996 Jun;28(6):563–566. doi: 10.1046/j.1365-2559.1996.d01-465.x. [DOI] [PubMed] [Google Scholar]
  49. Pinder S. E., Wencyk P., Sibbering D. M., Bell J. A., Elston C. W., Nicholson R., Robertson J. F., Blamey R. W., Ellis I. O. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer. 1995 Jan;71(1):146–149. doi: 10.1038/bjc.1995.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Poller D. N., Hutchings C. E., Galea M., Bell J. A., Nicholson R. A., Elston C. W., Blamey R. W., Ellis I. O. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor. Br J Cancer. 1992 Sep;66(3):583–588. doi: 10.1038/bjc.1992.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Poole G. H., Willsher P. C., Pinder S. E., Robertson J. F., Elston C. W., Blamey R. W. Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. Aust N Z J Surg. 1996 Sep;66(9):592–594. doi: 10.1111/j.1445-2197.1996.tb00825.x. [DOI] [PubMed] [Google Scholar]
  52. Robbins P., Pinder S., de Klerk N., Dawkins H., Harvey J., Sterrett G., Ellis I., Elston C. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol. 1995 Aug;26(8):873–879. doi: 10.1016/0046-8177(95)90010-1. [DOI] [PubMed] [Google Scholar]
  53. Robertson J. F., Bates K., Pearson D., Blamey R. W., Nicholson R. I. Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. Br J Cancer. 1992 May;65(5):727–730. doi: 10.1038/bjc.1992.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Robertson J. F., Ellis I. O., Pearson D., Elston C. W., Nicholson R. I., Blamey R. W. Biological factors of prognostic significance in locally advanced breast cancer. Breast Cancer Res Treat. 1994;29(3):259–264. doi: 10.1007/BF00666479. [DOI] [PubMed] [Google Scholar]
  55. Robinson I. A., McKee G., Nicholson A., D'Arcy J., Jackson P. A., Cook M. G., Kissin M. W. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 1994 Apr 16;343(8903):947–949. doi: 10.1016/s0140-6736(94)90066-3. [DOI] [PubMed] [Google Scholar]
  56. Sharifi S., Peterson M. K., Baum J. K., Raza S., Schnitt S. J. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol. 1999 Oct;12(10):941–945. [PubMed] [Google Scholar]
  57. Snead D. R., Vryenhoef P., Pinder S. E., Evans A., Wilson A. R., Blamey R. W., Elston C. W., Ellis I. O. Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates. Cytopathology. 1997 Aug;8(4):236–247. doi: 10.1046/j.1365-2303.1997.8682086.x. [DOI] [PubMed] [Google Scholar]
  58. Spriggs A. I. History of cytodiagnosis. J Clin Pathol. 1977 Dec;30(12):1091–1102. doi: 10.1136/jcp.30.12.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Todd J. H., Dowle C., Williams M. R., Elston C. W., Ellis I. O., Hinton C. P., Blamey R. W., Haybittle J. L. Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987 Oct;56(4):489–492. doi: 10.1038/bjc.1987.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Walker R. A., Camplejohn R. S. DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol. 1986 Sep;150(1):37–42. doi: 10.1002/path.1711500107. [DOI] [PubMed] [Google Scholar]
  61. Walker R. A., Senior P. V., Jones J. L., Critchley D. R., Varley J. M. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. J Pathol. 1989 Jun;158(2):97–105. doi: 10.1002/path.1711580204. [DOI] [PubMed] [Google Scholar]
  62. Watson D. P., McGuire M., Nicholson F., Given H. F. Aspiration cytology and its relevance to the diagnosis of solid tumors of the breast. Surg Gynecol Obstet. 1987 Nov;165(5):435–441. [PubMed] [Google Scholar]
  63. van Diest P. J., Mouriquand J., Schipper N. W., Baak J. P. Prognostic value of nucleolar morphometric variables in cytological breast cancer specimens. J Clin Pathol. 1990 Feb;43(2):157–159. doi: 10.1136/jcp.43.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES